BioMark Diagnostics Inc.
BMKDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$481 | -$416 | -$422 | -$335 |
| Dep. & Amort. | $86 | $100 | $227 | $58 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14 | $6 | $30 | $16 |
| Change in WC | -$107 | $15 | -$298 | $56 |
| Other Non-Cash | $6 | $9 | $12 | $14 |
| Operating Cash Flow | -$482 | -$286 | -$452 | -$190 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$2 | -$1 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $234 | -$1,882 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $824 | $0 | $0 | $0 |
| Investing Cash Flow | $1,050 | -$1,884 | -$1 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$36 | -$104 | -$104 | -$103 |
| Stock Issued | $0 | $0 | $3,611 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$22 | $4 | -$661 | $347 |
| Financing Cash Flow | -$58 | -$100 | $2,846 | $244 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $510 | -$2,270 | $2,393 | $54 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $212 | $2,482 | $89 | $35 |
| End Cash | $722 | $212 | $2,482 | $89 |
| Free Cash Flow | -$491 | -$288 | -$453 | -$190 |